Pharmacists’ Knowledge and Perceptions of FDA Approval Standards and the Breakthrough Therapy Designation

The “breakthrough therapy” designation (BTD) is a recent mechanism implemented by the United States Food and Drug Administration (FDA) to expedite access to drugs that address unmet needs. The purpose of this study is to describe pharmacists’ knowledge of FDA drug-approval standards and knowledge an...

Descripción completa

Detalles Bibliográficos
Autores principales: Herink, Megan C., Johnston, Kirbee, Breninger, Kristin, Wu, Erin, Irwin, Adriane N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9610476/
https://www.ncbi.nlm.nih.gov/pubmed/36287447
http://dx.doi.org/10.3390/pharmacy10050126

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9610476/
https://www.ncbi.nlm.nih.gov/pubmed/36287447
http://dx.doi.org/10.3390/pharmacy10050126

Ejemplares similares